Germany: Seufert advises on capital increase and investment of new shareholders in the bioinformatics company BioVariance
BioVariance GmbH offers bioinformatics services in the field of drug development, biomarker and target identification as well as translational and personalized medicine. Founded in 2013, the company has so far focused on complex biomedical data analysis and customer-specific software development for the pharmaceutical, biotechnology and healthcare sector.
With the investment funds acquired, the team around the founder and managing director aims to professionalise national and international sales, promote product development and new international market access, particularly in the US and in emerging markets in Africa, Eastern Europe and Asia.
Search ADVOC News